BenevolentAI is a fast-growing, UK-based company focused on the application of artificial intelligence to challenge and reinvent the current process of drug discovery & development. We have a range of drug discovery programmes ranging from exploratory work through to phase II clinical studies. Our portfolio of projects covers areas including, motor neurone disease, Parkinson’s Disease, various cancers, rare diseases and many others. We are one of the top 5 biggest private AI companies in the world and have raised over $200M in funding to drive our research based out of our sites in London, Cambridge & New York. As a cell biologist within BenevolentAI, you will make important contributions across our portfolio of current projects within our laboratories based at the Babraham Research Campus, Cambridge.
At BenevolentAI, we are reimagining the way drugs are discovered through the use of AI. An important part of this is characterisation of the best drug molecules through generation of the right in vitro data to rapidly accelerate identification of molecules for clinical use. As a key part of our Biological Sciences team, you’ll make important contributions to our projects to ensure that the value of our in vitro data is maximised and increased through AI methods.
Job Overview & Key Responsibilities:
In this role you’ll be working with scientists from our Cambridge, London and New York offices as well as an external network of collaborators so excellent communication skills are a must. You’ll also be flexible in your approach and fun to work with!
BenevolentAI is offering a highly competitive package. Benefits will include a contributory pension scheme, life cover and private medical insurance.
How to apply
If you would like to be considered for this role, please apply here outlining your suitability for this role, your current salary and providing your CV.
The closing date for applications is 31st May 2018.